Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsHSC-derived Mixed Lineage Leukemia- acute myeloid leukemia gene fusions was highly resistant to chemotherapy and expressed elevated amounts of the multispecific anion transporter ABCC3.
[Science Translational Medicine]
6445212 RW4CIMPU items 1 apa 0 default asc 1 159456 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-bef0431be36cb67a26ae4eb3e069e34c%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22RW4CIMPU%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zeisig%20et%20al.%22%2C%22parsedDate%22%3A%222021-02-24%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZeisig%2C%20B.%20B.%2C%20Fung%2C%20T.%20K.%2C%20Zarowiecki%2C%20M.%2C%20Tsai%2C%20C.%20T.%2C%20Luo%2C%20H.%2C%20Stanojevic%2C%20B.%2C%20Lynn%2C%20C.%2C%20Leung%2C%20A.%20Y.%20H.%2C%20Zuna%2C%20J.%2C%20Zaliova%2C%20M.%2C%20Bornhauser%2C%20M.%2C%20Bonin%2C%20M.%20von%2C%20Lenhard%2C%20B.%2C%20Huang%2C%20S.%2C%20Mufti%2C%20G.%20J.%2C%20%26amp%3B%20So%2C%20C.%20W.%20E.%20%282021%29.%20Functional%20reconstruction%20of%20human%20AML%20reveals%20stem%20cell%20origin%20and%20vulnerability%20of%20treatment-resistant%20MLL-rearranged%20leukemia.%20%3Ci%3EScience%20Translational%20Medicine%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%28582%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscitranslmed.abc4822%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fscitranslmed.abc4822%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DRW4CIMPU%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Functional%20reconstruction%20of%20human%20AML%20reveals%20stem%20cell%20origin%20and%20vulnerability%20of%20treatment-resistant%20MLL-rearranged%20leukemia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernd%20B.%22%2C%22lastName%22%3A%22Zeisig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsz%20Kan%22%2C%22lastName%22%3A%22Fung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Magdalena%22%2C%22lastName%22%3A%22Zarowiecki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiou%20Tsun%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Huacheng%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boban%22%2C%22lastName%22%3A%22Stanojevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Lynn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anskar%20Y.%20H.%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Zuna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marketa%22%2C%22lastName%22%3A%22Zaliova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Bornhauser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malte%20von%22%2C%22lastName%22%3A%22Bonin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Boris%22%2C%22lastName%22%3A%22Lenhard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suming%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghulam%20J.%22%2C%22lastName%22%3A%22Mufti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20Wai%20Eric%22%2C%22lastName%22%3A%22So%22%7D%5D%2C%22abstractNote%22%3A%22An%20origin-al%20leukemia%20treatment%20strategy%5CnThe%20heterogeneity%20of%20acute%20myeloid%20leukemia%20%28AML%29%20has%20problematized%20understanding%20this%20cancer%5Cu2019s%20cell%20of%20origin%20and%20the%20role%20that%20this%20origin%20might%20play%20in%20the%20onset%20of%20treatment%20resistance.%20Zeisig%20et%20al.%20used%20cord%20blood%20and%20cells%20from%20patients%20with%20primary%20MLL-rearranged%20AML%20to%20determine%20that%20most%20MLL-AML%20cells%20are%20derived%20from%20either%20hematopoietic%20stem%20cells%20%28HSCs%29%20or%20common%20myeloid%20progenitor%20cells.%20They%20further%20showed%20that%20the%20ABCC3%20inhibitor%20fidaxomicin%20together%20with%20doxorubicin%20extended%20survival%20in%20mouse%20models%20of%20treatment%20resistant%20MLL-AML%20derived%20from%20specifically%20HSCs.%20This%20work%20could%20have%20implications%20for%20the%20clinical%20treatment%20of%20AML%20with%20MLL%20rearrangement.%5CnChemoresistance%20remains%20the%20major%20challenge%20for%20successful%20treatment%20of%20acute%20myeloid%20leukemia%20%28AML%29.%20Although%20recent%20mouse%20studies%20suggest%20that%20treatment%20response%20of%20genetically%20and%20immunophenotypically%20indistinguishable%20AML%20can%20be%20influenced%20by%20their%20different%20cells%20of%20origin%2C%20corresponding%20evidence%20in%20human%20disease%20is%20still%20largely%20lacking.%20By%20combining%20prospective%20disease%20modeling%20using%20highly%20purified%20human%20hematopoietic%20stem%20or%20progenitor%20cells%20with%20retrospective%20deconvolution%20study%20of%20leukemia%20stem%20cells%20%28LSCs%29%20from%20primary%20patient%20samples%2C%20we%20identified%20human%20hematopoietic%20stem%20cells%20%28HSCs%29%20and%20common%20myeloid%20progenitors%20%28CMPs%29%20as%20two%20distinctive%20origins%20of%20human%20AML%20driven%20by%20Mixed%20Lineage%20Leukemia%20%28MLL%29%20gene%20fusions%20%28MLL-AML%29.%20Despite%20LSCs%20from%20either%20MLL-rearranged%20HSCs%20or%20MLL-rearranged%20CMPs%20having%20a%20mature%20CD34%5Cu2212%5C%2Flo%5C%2FCD38%2B%20immunophenotype%20in%20both%20a%20humanized%20mouse%20model%20and%20primary%20patient%20samples%2C%20the%20resulting%20AML%20cells%20exhibited%20contrasting%20responses%20to%20chemotherapy.%20HSC-derived%20MLL-AML%20was%20highly%20resistant%20to%20chemotherapy%20and%20expressed%20elevated%20amounts%20of%20the%20multispecific%20anion%20transporter%20ABCC3.%20Inhibition%20of%20ABCC3%20by%20shRNA-mediated%20knockdown%20or%20with%20small-molecule%20inhibitor%20fidaxomicin%2C%20currently%20used%20for%20diarrhea%20associated%20with%20Clostridium%20difficile%20infection%2C%20effectively%20resensitized%20HSC-derived%20MLL-AML%20toward%20standard%20chemotherapeutic%20drugs.%20This%20study%20not%20only%20functionally%20established%20two%20distinctive%20origins%20of%20human%20LSCs%20for%20MLL-AML%20and%20their%20role%20in%20mediating%20chemoresistance%20but%20also%20identified%20a%20potential%20therapeutic%20avenue%20for%20stem%20cell%5Cu2013associated%20treatment%20resistance%20by%20repurposing%20a%20well-tolerated%20antidiarrhea%20drug%20already%20used%20in%20the%20clinic.%5CnChemoresistant%20human%20CD34%5Cu2212%5C%2Flo%5C%2FCD38%2B%20MLL%20leukemic%20stem%20cells%20originate%20from%20HSCs%20and%20can%20be%20resensitized%20by%20targeting%20ABCC3%20with%20fidaxomicin.%5CnChemoresistant%20human%20CD34%5Cu2212%5C%2Flo%5C%2FCD38%2B%20MLL%20leukemic%20stem%20cells%20originate%20from%20HSCs%20and%20can%20be%20resensitized%20by%20targeting%20ABCC3%20with%20fidaxomicin.%22%2C%22date%22%3A%222021%5C%2F02%5C%2F24%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1126%5C%2Fscitranslmed.abc4822%22%2C%22ISSN%22%3A%221946-6234%2C%201946-6242%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fstm.sciencemag.org%5C%2Fcontent%5C%2F13%5C%2F582%5C%2Feabc4822%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-02-25T17%3A14%3A04Z%22%7D%7D%5D%7D
Zeisig, B. B., Fung, T. K., Zarowiecki, M., Tsai, C. T., Luo, H., Stanojevic, B., Lynn, C., Leung, A. Y. H., Zuna, J., Zaliova, M., Bornhauser, M., Bonin, M. von, Lenhard, B., Huang, S., Mufti, G. J., & So, C. W. E. (2021). Functional reconstruction of human AML reveals stem cell origin and vulnerability of treatment-resistant MLL-rearranged leukemia. Science Translational Medicine, 13(582). https://doi.org/10.1126/scitranslmed.abc4822 Cite
